Back

New Investment: Bonusan

bd-capital, the pan-European operator-led investment firm, is pleased to announce its partnership with Bonusan, a Netherlands-based healthcare company, with the strategy to accelerate growth and unlock the potential of the Bonusan brand, reputation and team in the Netherlands and across Europe.

Bonusan is a healthcare company with 120 years’ experience in food supplements, with formulations based on science and insights gained from healthcare professionals. Four generations of the Bogaerds family have created an authority in the market of food supplements, driven by passion and entrepreneurship.

Demand for personalised healthcare solutions continues to grow rapidly on the back of increasing focus on preventative healthcare and an ageing population. Bonusan’s mission is to access this growth by providing more people with access to its knowledge, its network of healthcare professionals and its high-quality, science-based products.

Partnership with the Bogaerds family

 

The Bogaerds family initiated the search for a partner who would support the growth of the business while sharing their vision of maintaining the high-quality standards of Bonusan’s products. The partnership with bd-capital will allow Bonusan and the Natura Foundation, its education and training platform for healthcare professionals, to increase their reach and make more of a positive impact on health and wellbeing for consumers across Europe. bd-capital attributes great significance to the Bonusan history, its value-add to healthcare professionals and their clients, and the important role of the Natura Foundation as a leading training institute and knowledge centre in its field.

Rik Boagaerds commented:

“We are very pleased to announce our partnership with bd-capital, allowing us to increase our relevance to current and future customers and partners. The partnership increases our potential to invest in R&D and innovation and will enable us to enlarge the reach of our products, services, and training programs. We share the same values and strategic objectives, and together with our customers and partners we can apply our joint expertise to have a positive influence on the health and wellbeing of an ever-increasing number of people.”

bd-capital’s healthcare expertise

 

bd-capital is a private equity firm focused on healthcare products and services, consumer products, and tech-enabled services. The bd-capital team consists of investment professionals and operators with broad experience in healthcare, including food supplements, pharmacy, and healthcare services. The team also brings extensive experience in e-commerce and international expansion. In 2020, bd-capital partnered with the founder of Symprove, a UK-based unique water-based probiotic. Symprove is achieving rapid growth with a loyal group of users who take it on a daily basis to support their gut microbiome.

Bram Grimmelt, Partner at bd-capital, added:

“In the last few years we have seen many companies active in Vitamins, Minerals and Supplements across Europe. We believe that Bonusan differentiates itself with its high-quality products based on decades of experience in product development and innovation, deep industry knowledge via its knowledge and training institute, the Natura Foundation, and its in-house production facility. We look forward to continuing the international expansion of Bonusan in partnership with the Bogaerds family and management.”

 

Rik Bogaerds will join the Supervisory Board of Bonusan, and daily management will continue to be led by Marchien van Hulst and Hans Jungerhans. They will be supported by Richard Learwood, Operational Partner at bd-capital and industry expert.

For more information visit www.bonusan.com.